Vaccines to Prevent Infections by OncovirusesSCHILLER, John T; LOWY, Douglas R.Annual review of microbiology. 2010, Vol 64, pp 23-41, issn 0066-4227, 19 p.Article

Prospects for cervical cancer prevention by human papillomavirus vaccinationSCHILLER, John T; LOWY, Douglas R.Cancer research (Baltimore). 2006, Vol 66, Num 21, pp 10229-10232, issn 0008-5472, 4 p.Article

Papillomavirus-like particle vaccinesSCHILLER, John T; LOWY, Douglas R.Journal of the National Cancer Institute. Monographs. 2000, Num 28, pp 50-54, issn 1052-6773Conference Paper

Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus CapsidsDAY, Patricia M; LOWY, Douglas R; SCHILLER, John T et al.Journal of virology. 2008, Vol 82, Num 24, pp 12565-12568, issn 0022-538X, 4 p.Article

Prophylactic HPV vaccines : Underlying mechanismsSTANLEY, Margaret; LOWY, Douglas R; FRAZER, Ian et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.106-S3.113Article

HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and WomenGILLISON, Maura L; CHATURVEDI, Anil K; LOWY, Douglas R et al.Cancer. 2008, Vol 113, Num 10, pp 3036-3046, issn 0008-543X, 11 p., SUPArticle

Efficient intracellular assembly of papillomaviral vectorsBUCK, Christopher B; PASTRANA, Diana V; LOWY, Douglas R et al.Journal of virology. 2004, Vol 78, Num 2, pp 751-757, issn 0022-538X, 7 p.Article

Human Papillomavirus Infection and the Primary and Secondary Prevention of Cervical CancerLOWY, Douglas R; SOLOMON, Diane; HILDESHEIM, Allan et al.Cancer. 2008, Vol 113, Num 7, pp 1980-1993, issn 0008-543X, 14 p., 1Article

Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virusCHACKERIAN, Bryce; BRIGLIO, Lindsey; ALBERT, Paul S et al.Journal of virology. 2004, Vol 78, Num 8, pp 4037-4047, issn 0022-538X, 11 p.Article

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 VaccineKREIMER, Aimee R; RODRIGUEZ, Ana Cecilia; LOWY, Douglas R et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 19, pp 1444-1451, issn 0027-8874, 8 p.Article

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineNARDELLI-HAEFLIGER, Denise; LURATI, Floriana; WIRTHNER, Daniel et al.Vaccine. 2005, Vol 23, Num 28, pp 3634-3641, issn 0264-410X, 8 p.Article

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cellsLENZ, Petra; THOMPSON, Cynthia D; DAY, Patricia M et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 231-237, issn 1521-6616, 7 p.Article

Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine TrialLANG KUHS, Krystle A; GONZALEZ, Paula; DELVECCHIO, Corey et al.The Journal of infectious diseases. 2014, Vol 210, Num 12, pp 1890-1899, issn 0022-1899, 10 p.Article

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionKEMP, Troy J; HILDESHEIM, Allan; SAFAEIAN, Mahboobeh et al.Vaccine. 2011, Vol 29, Num 11, pp 2011-2014, issn 0264-410X, 4 p.Article

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesNARDELLI-HAEFLIGER, Denise; WIRTHNER, Daniel; SCHILLER, John T et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 15, pp 1128-1137, issn 0027-8874, 10 p.Article

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine TrialSAFAEIAN, Mahboobeh; PORRAS, Carolina; HERRERO, Rolando et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 11, pp 1242-1250, issn 1940-6207, 9 p.Article

The transcription factor Gfi 1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1DE LA LUZ SIERRA, Maria; SAKAKIBARA, Shuhei; XIAOLAN QIAN et al.Blood. 2010, Vol 115, Num 19, pp 3970-3979, issn 0006-4971, 10 p.Article

Maturation of papillomavirus capsidsBUCK, Christopher B; THOMPSON, Cynthia D; PANG, Yuk-Ying S et al.Journal of virology. 2005, Vol 79, Num 5, pp 2839-2846, issn 0022-538X, 8 p.Article

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccineHARRO, Clayton D; PANG, Yuk-Ying Susana; DILLNER, Joakim et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 4, pp 284-292, issn 0027-8874Article

High-risk human papillomavirus is sexually transmitted : Evidence from a follow-up study of virgins starting sexual activity (intercourse)KJAER, Susanne Krüger; CHACKERIAN, Bryce; MEIJER, Chris L. M et al.Cancer epidemiology, biomarkers & prevention. 2001, Vol 10, Num 2, pp 101-106, issn 1055-9965Conference Paper

Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer CellsXIAOLI DU; XIAOLAN QIAN; PAPAGEORGE, Alex et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 17, pp 4405-4416, issn 0008-5472, 12 p.Article

Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15^INK4b and p16^Ink4a, Leading to Neoplastic Transformation and Poor Prognosis in Human CancerXIAOLAN QIAN; DURKIN, Marian E; DUNRUI WANG et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 22, pp 5900-5911, issn 0008-5472, 12 p.Article

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix^®KEMP, TroyJ; SAFAEIAN, Mahboobeh; HILDESHEIM, Allan et al.Vaccine. 2012, Vol 31, Num 1, pp 165-170, issn 0264-410X, 6 p.Article

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection : A randomized trial. CommentaryHILDESHEIM, Allan; HERRERO, Rolando; JIMENEZ, Silvia E et al.JAMA, the journal of the American Medical Association. 2007, Vol 298, Num 7, issn 0098-7484, 743-753, 805-806 [13 p.]Article

HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodPINTO, Ligia A; CASTLE, Philip E; BERZOFSKY, Jay A et al.Vaccine. 2005, Vol 23, Num 27, pp 3555-3564, issn 0264-410X, 10 p.Article